These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 30999209

  • 1. Cluster binding studies with two anti-Thomsen-Friedenreich (anti-core-1, CD176, TF) antibodies: Evidence for a multiple TF epitope.
    Flechner A, Butschak G, Löffler A, Rühmann J, Nishimura SI, Dölling R, Purfürst B, Goletz S, Danielczyk A, Karsten U.
    Int Immunopharmacol; 2019 Jul; 72():186-194. PubMed ID: 30999209
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of the anti-Thomsen-Friedenreich antibodies Nemod-TF1 and Nemod-TF2 as prognostic markers in breast cancer.
    Heublein S, Egger M, Zhu J, Berger L, Mayr D, Schindlbeck C, Kuhn C, Hofmann SS, Schuetz F, Jeschke U, Ditsch N.
    Breast Cancer Res Treat; 2020 Feb; 179(3):643-652. PubMed ID: 31828591
    [Abstract] [Full Text] [Related]

  • 3. Increased sialylation of anti-Thomsen-Friedenreich antigen (CD176) antibodies in patients with gastric cancer: a diagnostic and prognostic potential.
    Kurtenkov O, Izotova J, Klaamas K, Sergeyev B.
    Biomed Res Int; 2014 Feb; 2014():830847. PubMed ID: 25276822
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Profiling of Naturally Occurring Antibodies to the Thomsen-Friedenreich Antigen in Health and Cancer: The Diversity and Clinical Potential.
    Kurtenkov O.
    Biomed Res Int; 2020 Feb; 2020():9747040. PubMed ID: 32280709
    [Abstract] [Full Text] [Related]

  • 8. Monoclonal antibody BW835 defines a site-specific Thomsen-Friedenreich disaccharide linked to threonine within the VTSA motif of MUC1 tandem repeats.
    Hanisch FG, Stadie T, Bosslet K.
    Cancer Res; 1995 Sep 15; 55(18):4036-40. PubMed ID: 7545084
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. TF-containing MUC1 glycopeptides fail to entice Galectin-1 recognition of tumor-associated Thomsen-Freidenreich (TF) antigen (CD176) in solution.
    FitzGerald FG, Rodriguez Benavente MC, Garcia C, Rivero Y, Singh Y, Wang H, Fields GB, Cudic M.
    Glycoconj J; 2020 Dec 15; 37(6):657-666. PubMed ID: 33001366
    [Abstract] [Full Text] [Related]

  • 11. Increased Avidity of the Sambucus nigra Lectin-Reactive Antibodies to the Thomsen-Friedenreich Antigen as a Potential Biomarker for Gastric Cancer.
    Kurtenkov O, Klaamas K.
    Dis Markers; 2015 Dec 15; 2015():761908. PubMed ID: 26663951
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Isolation and characterization of thomsen-friedenreich-specific antibodies from human serum.
    Butschak G, Karsten U.
    Tumour Biol; 2002 Dec 15; 23(3):113-22. PubMed ID: 12218291
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. CD176 antiserum treatment leads to a therapeutic response in a murine model of leukemia.
    Yi B, Zhang Z, Zhang M, Schwartz-Albiez R, Cao Y.
    Oncol Rep; 2013 Oct 15; 30(4):1841-7. PubMed ID: 23900643
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A new monoclonal antibody (A78-G/A7) to the Thomsen-Friedenreich pan-tumor antigen.
    Karsten U, Butschak G, Cao Y, Goletz S, Hanisch FG.
    Hybridoma; 1995 Feb 15; 14(1):37-44. PubMed ID: 7539400
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Human monoclonal antibodies specific for the tumour associated Thomsen-Friedenreich antigen.
    Dahlenborg K, Hultman L, Carlsson R, Jansson B.
    Int J Cancer; 1997 Jan 06; 70(1):63-71. PubMed ID: 8985092
    [Abstract] [Full Text] [Related]

  • 20. Development, characterization, and immunotherapeutic use of peptide mimics of the Thomsen-Friedenreich carbohydrate antigen.
    Heimburg-Molinaro J, Almogren A, Morey S, Glinskii OV, Roy R, Wilding GE, Cheng RP, Glinsky VV, Rittenhouse-Olson K.
    Neoplasia; 2009 Aug 06; 11(8):780-92. PubMed ID: 19649208
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.